Neurotrack's competitors

Neurotrack's competitors include NeuraLace Medical, EXACT Sciences, bioMerieux and AbleTo
Add company...
Neurotrack
Neurotrack's technology can predict the onset of Alzheimer's disease three to six years before symptoms occur.
NeuraLace Medical
NeuraLace Medical has developed a proprietary neuromodulation platform for direct and selective stimulation of sensory nerve fibers to manage neuropathic pain.
EXACT Sciences
Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.
bioMerieux
bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety.
AbleTo
AbleTo is a technology-enabled provider of mental health care.
Founding Date
Founding Date
2012
Founding Date
2016
Founding Date
1995
Founding Date
1963
Founding Date
2008
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Redwood City, US HQ
Locations
San Diego, US HQ
Locations
Madison, US HQ
Locations
Marcy-l'Étoile, FR HQ
Locations
New York, US HQ
Employees
Employees
254% increase
Employees
8
Employees
736
Employees
9,8065% increase
Employees
2275% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
6.4 b
Valuation ($)
9.3 b
Valuation ($)
N/A
Facebook likes
Facebook likes
3.4 k
Facebook likes
N/A
Facebook likes
5.4 k
Facebook likes
8.5 k
Facebook likes
785
Twitter followers
Twitter followers
1.3 k
Twitter followers
22
Twitter followers
2 k
Twitter followers
4.8 k
Twitter followers
856

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$99.4m (FY, 2016)
Revenue (est.)
€2.1b (FY, 2016)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$45.2m (FY, 2016)
Cost of goods
€1b (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$54.2m (FY, 2016)
Gross profit
€1.1b (FY, 2016)
Gross profit
N/A
Net income
Net income
N/A
Net income
N/A
Net income
($167.2m) (FY, 2016)
Net income
€179.2m (FY, 2016)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 13.7m (2 months ago)
Latest funding round
$ 2m (about 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 36.6m (9 months ago)
Total funding raised
Total funding raised
$ 26.1m
Total funding raised
$ 2m
Total funding raised
$ 8.2m
Total funding raised
N/A
Total funding raised
$ 36.6m
For sources of this data, please see the company profileDownload Excel

View company profiles

NeuraLace Medical
HQ
San Diego, US
Employees
8

NeuraLace Medical has developed a proprietary neuromodulation platform for direct and selective stimulation of sensory nerve fibers to manage neuropathic pain.

View company
EXACT Sciences
HQ
Madison, US
Employees
736

Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.

View company
bioMerieux
HQ
Marcy-l'Étoile, FR
Employees
9,806↑ 5% increase

bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety.

View company
AbleTo
HQ
New York, US
Employees
227↑ 5% increase

AbleTo is a technology-enabled provider of mental health care.

View company